← Open Payments lookup

SAWRABHYA KALAPURAKKAL: Open Payments

NPI 1639636699 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,962 in 165 payments from 19 companies in 2025. Trend: 2023 $255 · 2024 $1,538 · 2025 $3,962

Food & beverage: $3,962
CompanyPaymentsAmount
Janssen Biotech, Inc.34$804
Madrigal Pharmaceuticals14$594
ABBVIE INC.29$507
Takeda Pharmaceuticals U.S.A., Inc.17$373
Ardelyx, Inc.15$322
GENZYME CORPORATION7$245
Lilly USA, LLC10$233
Aimmune Therapeutics, Inc.11$214
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$206
Phathom Pharmaceuticals, Inc.1$117

Products named: TREMFYA, REZDIFFRA, IBSRELA, DUPIXENT, ZENPEP, OMVOH, XIFAXAN, ENTYVIO.

Industry payments across FL — which companies pay providers there.